Publication: International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up
| dc.contributor.author | Altassan, Ruqaiah | |
| dc.contributor.author | Péanne, Romain | |
| dc.contributor.author | Jaeken, Jaak | |
| dc.contributor.author | Barone, Rita | |
| dc.contributor.author | Borgel, Delphine | |
| dc.contributor.author | Brasil, Sandra | |
| dc.contributor.author | Cassiman, David | |
| dc.contributor.author | Cechova, Anna | |
| dc.contributor.author | Coman, David | |
| dc.contributor.author | Corral, Javier | |
| dc.contributor.author | Correia, Joana | |
| dc.contributor.author | Morena-Barrio, María Eugenia de la | |
| dc.contributor.author | Lonlay, Pascale de | |
| dc.contributor.author | Dos Reis, Vanessa | |
| dc.contributor.author | Ferreira, Carlos R | |
| dc.contributor.author | Fiumara, Agata | |
| dc.contributor.author | Francisco, Rita | |
| dc.contributor.author | Freeze, Hudson | |
| dc.contributor.author | Funke, Simone | |
| dc.contributor.author | Gardeitchik, Thatjana | |
| dc.contributor.author | Matthijs, Gert | |
| dc.contributor.author | Girad, Muriel | |
| dc.contributor.author | Giros, Marisa | |
| dc.contributor.author | Grünewald, Stephanie | |
| dc.contributor.author | Honzik, Tomas | |
| dc.contributor.author | Hutter, Marlen | |
| dc.contributor.author | Krasnewich, Donna | |
| dc.contributor.author | Lam, Christina | |
| dc.contributor.author | Lee, Joy | |
| dc.contributor.author | Lefeber, Dirk | |
| dc.contributor.author | Marques-de-Silva, Dorinda | |
| dc.contributor.author | Martinez, Antonio F | |
| dc.contributor.author | Moravej, Hossein | |
| dc.contributor.author | Õunap, Katrin | |
| dc.contributor.author | Pascoal, Carlota | |
| dc.contributor.author | Pascreau, Tiffany | |
| dc.contributor.author | Patterson, Marc | |
| dc.contributor.author | Quelhas, Dulce | |
| dc.contributor.author | Raymond, Kimiyo | |
| dc.contributor.author | Sarkhail, Peymaneh | |
| dc.contributor.author | Schiff, Manuel | |
| dc.contributor.author | Seroczyńska, Małgorzata | |
| dc.contributor.author | Serrano, Mercedes | |
| dc.contributor.author | Seta, Nathalie | |
| dc.contributor.author | Sykut-Cegielska, Jolanta | |
| dc.contributor.author | Thiel, Christian | |
| dc.contributor.author | Tort, Federic | |
| dc.contributor.author | Vals, Mari-Anne | |
| dc.contributor.author | Videira, Paula | |
| dc.contributor.author | Witters, Peter | |
| dc.contributor.author | Zeevaert, Renate | |
| dc.contributor.author | Morava, Eva | |
| dc.contributor.author | Hernández Caselles, Trinidad | |
| dc.contributor.department | Bioquímica y Biología Molecular B e Inmunología | |
| dc.date.accessioned | 2024-02-08T08:00:14Z | |
| dc.date.available | 2024-02-08T08:00:14Z | |
| dc.date.copyright | © 2019 SSIEM | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Phosphomannomutase 2 (PMM2-CDG) is the most common congenital disorder of N-glycosylation and is caused by a deficient PMM2 activity. The clinical presentation and the onset of PMM2-CDG vary among affected individuals ranging from a severe antenatal presentation with multisystem involvement to mild adulthood presentation limited to minor neurological involvement. Management of affected patients requires a multidisciplinary approach. In this article, a systematic review of the literature on PMM2-CDG was conducted by a group of international experts in different aspects of CDG. Our managment guidelines were initiated based on the available evidence-based data and experts' opinions. This guideline mainly addresses the clinical evaluation of each system/organ involved in PMM2-CDG, and the recommended management approach. It is the first systematic review of current practices in PMM2-CDG and the first guidelines aiming at establishing a practical approach to the recognition, diagnosis and management of PMM2-CDG patients. | es |
| dc.format | application/pdf | es |
| dc.format.extent | 24 | es |
| dc.identifier.citation | Journal of Inherited Metabolic Disease 2019 ,42(1):5-28. | |
| dc.identifier.doi | https://doi.org/10.1002/jimd.12024 | |
| dc.identifier.issn | Print: 0141-8955 | |
| dc.identifier.issn | Electronic: 1573-2665 | |
| dc.identifier.uri | http://hdl.handle.net/10201/138944 | |
| dc.language | eng | es |
| dc.publisher | WILEY | es |
| dc.relation | Metabolic ERN (MetabERN) | es |
| dc.rights.accessRights | info:eu-repo/semantics/restrictedAccess | |
| dc.subject | PMM2-CDG | es |
| dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina | es |
| dc.title | International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
| relation.isAuthorOfPublication | c0416b92-3bd1-4c0a-bd7c-df5ae58f3f63 | |
| relation.isAuthorOfPublication.latestForDiscovery | c0416b92-3bd1-4c0a-bd7c-df5ae58f3f63 |
Collections
Sin licencia Creative Commons.